Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis

NCT04043897 is registered in ClinicalTrials.gov with Eugene F Yen, MD as lead sponsor.

NCT NCT04043897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04043897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis
Lead sponsor
Eugene F Yen, MD
Phase
Phase 2
Overall status
Recruiting
Start date
June 29, 2018
Completion date
December 31, 2021
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microscopic colitis